In the current study, we analyzed the relationships between HYAL3 expression levels, clinical features, and overall survival (OS) in patients with BLCA, utilizing The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and the Human Protein Atlas databases. Here, HYAL3 is linked to bladder transitional cell carcinoma.